Guardant Health
GH
#3235
Rank
NZ$6.19 B
Marketcap
$50.15
Share price
1.26%
Change (1 day)
30.62%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -NZ$0.8 Billion

According to Guardant Health 's latest financial reports the company's current earnings are NZ$0.64 Billion. In 2023 the company made an earning of -NZ$0.81 Billion, an increase over its 2022 earnings that were of -NZ$1.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.8 Billion-0.98%
2023 -NZ$0.81 Billion-26.73%
2022 -NZ$1.11 Billion69.96%
2021 -NZ$0.65 Billion56.35%
2020 -NZ$0.42 Billion252.69%
2019 -NZ$0.12 Billion-17.22%
2018 -NZ$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.49 Billion-40.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$53.27 Million-93.56%๐Ÿ‡บ๐Ÿ‡ธ USA